H.R. 6269: Ban Poisonous Additives Act of 2016

Before you vote › Federal bills

H.R. 6269: Ban Poisonous Additives Act of 2016

114th Congress · introduced 2016-09-28 · Health · Latest: Referred to the House Committee on Energy and Commerce.

federal

Save to my notebook What does this mean? Print

Official title

Ban Poisonous Additives Act of 2016

Plain summary

Ban Poisonous Additives Act of 2016 This bill bans food containers composed, in whole or in part, of bisphenol A (BPA). The Food and Drug Administration (FDA) may grant waivers to a facility for a particular product if the facility: (1) demonstrates that it is not technologically feasible to replace BPA in the container or to use a BPA-free container, and (2) submits to the FDA a plan and time line for removing BPA from the container. Products granted a waiver must include a warning on the label. The FDA must promote and facilitate the use of BPA replacements. BPA may not be replaced with substances that: (1) are known or likely human carcinogens; (2) have been found by the Environmental Protection Agency (EPA) to be persistent, bioaccumulative, and toxic; (3) cause reproductive or developmental toxicity; or (4) are endocrine disrupting chemicals. The FDA must review substances that may be found in food, including food additives and food contact substances, and take remedial action if it does not determine that there is a reasonable certainty that no harm will result from aggregate exposure, taking into consideration potential adverse effects from low-dose exposure and the effects on vulnerable populations and populations with high exposure. This bill amends the Federal Food, Drug, and Cosmetic Act to require the manufacturer or supplier of a food contact substance to notify the FDA of the identity and intended use of the substance prior to its introduction into interstate commerce and that: (1) no adverse health effects result from low-dose exposures to the substance, and (2) the substance has not been shown to cause reproductive or developmental toxicity in humans or animals.

Congressional Research Service summary (Introduced in House), quoted unchanged (nonpartisan). Read the source.

What a vote does

PSI Sci description of the legislative step (not an opinion).

The strongest published arguments

Alternatives

Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.

How did my representative vote? · This bill's floor votes

Officials and money

Sponsor: Rep. Meng, Grace [D-NY-6] · 1 cosponsors

Cost estimate: No cost estimate published yet.

Cosponsors on this site

Ted Lieu (D-CA)

Sponsor's campaign money: Rep. Meng, Grace [D-NY-6] reported raising $2.2 million (2025–2026). Details. Shown for context only; it does not mean any donor supported this bill.

No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.

Sources

• Congressional Research Service summary (Introduced in House)
• Congress.gov
• Data: GovInfo BILLSTATUS bulk data (Library of Congress), BILLSTATUS-114hr6269.xml <https://www.govinfo.gov/bulkdata/BILLSTATUS/114/hr>

Record fed-us-cong114-hr6269 · catalog fed-us-congress-bills-cong114 · updated 2026-11-15 by psicol fed-bills-cong114